Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes. Authors' reply

Saved in:
Bibliographic Details
Published inPolskie archiwum medycyny wewne̦trznej Vol. 130; no. 10; pp. 920 - 921
Main Authors Kosmaczewska, Agata, Frydecka, Irena
Format Journal Article
LanguageEnglish
Published Poland 29.10.2020
Subjects
Betacoronavirus
Coronavirus
Coronavirus Infections
COVID-19
Cystic Fibrosis
Humans
Immune System
Interleukin-6
Pandemics
Pneumonia, Viral
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1897-9483
1897-9483
DOI:10.20452/pamw.15660